LA-Bac8c

• UNSPSC Description:

  LA-Bac8c is a Lipoic acid modified antimicrobial peptide with enhanced antimicrobial properties. LA-Bac8c inhibits S. aureus, MRSA, S. epidermidis, E. coli, and P. aeruginosa with MICs of 1, 4, 8, 8, and 8 μg/mL[1].

• Target Antigen:

  Antibiotic; Bacterial

• Type:

  Peptides

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/la-bac8c.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C([C@@H](NC(CCCC[C@@H]1CCSS1)=O)CCCNC(N)=N)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CC2=CNC3=CC=CC=C23)=O)[C@H](CC)C)=O)C(C)C)=O)CC4=CNC5=CC=CC=C45)=O)[C@H](CC)C

• Molecular Weight:

  1371.76

• References & Citations:

  [1]Wenya Zhou, et al. Lipoic acid modified antimicrobial peptide with enhanced antimicrobial properties. Bioorg Med Chem. 2020 Oct 1;28(19):115682.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported